MTS Health Investors Completes Recapitalization of Medical Knowledge Group, LLC

07:30 EDT 9 Aug 2017 | Businesswire

MTS Health Investors, LLC (“MTS”), the New York-based healthcare private equity firm, announced that funds managed by MTS have completed a recapitalization of Medical Knowledge Group, LLC (“Medical Knowledge Group” or the “Company”). Headquartered in New York City, Medical Knowledge Group is an analytics-driven and technology-enabled multi-channel healthcare marketing and communications provider servicing the biopharmaceutical industry. MTS has partnered with Medical Knowledge Group’s existing senior management team to recapitalize the business and to provide additional capital to support future growth. The existing management team will maintain a significant minority ownership position in the Company going forward. Terms of the transaction were not disclosed.

Leon Behar, Medical Knowledge Group’s Chief Executive Officer, commented, “We are excited to partner with MTS as we enter the next phase of our growth strategy. MTS’s extensive knowledge of the healthcare space and strong network of relationships make them the ideal partner to help us provide additional value to our clients and identify new avenues for growth.”

“We are pleased to be partnering with Medical Knowledge Group’s talented leadership team,” said CJ Burnes, Principal with MTS. “The Medical Knowledge Group team has built a clear and differentiated market leader in the technology-enabled medical communications space. The Company has an exceptional reputation for translating complex science into highly effective market shaping strategies through the integration of their marketing and medical expertise with sophisticated data analytics capabilities. We look forward to supporting their continued growth.”

MTS Senior Managing Director, Curtis Lane, said, “Our investment in Medical Knowledge Group is consistent with MTS’s investment strategy to proactively identify market leaders in targeted healthcare industry sectors. MTS has spent significant time evaluating opportunities in the technology-enabled pharma services sector and we believe that Medical Knowledge Group represents an ideal investment platform for MTS to provide additional financial and operational resources and to pursue new opportunities for growth.”

About Medical Knowledge Group

Medical Knowledge Group is a New York based, independent analytics-driven and technology-enabled multi-channel marketing solutions provider serving marketing, medical affairs, and stakeholder relations teams at biopharmaceutical companies throughout the entire product lifecycle. Medical Knowledge Group has a diverse roster of clients ranging from niche biotech and diagnostic companies to some of the world’s largest companies in the industry. The Company is an analytics-centric, strategic marketing solutions provider that partners with clients to translate the complex science and abundant data behind their brands into market shaping strategies that maximize their commercial potential.

About MTS

MTS Health Investors, LLC ("MTS") makes equity investments in companies that operate within the services sectors of the healthcare industry. We focus on companies with profitable business models and a demonstrated ability to deliver cost-effective solutions. MTS manages over $700 million in investments and is currently investing out of its fourth fund. We are based in New York City and invest in companies throughout the United States.

For more information, please email us at

Owen Blicksilver Public Relations, Inc.
Caroline Luz, 203-656-2829


More From BioPortfolio on "MTS Health Investors Completes Recapitalization of Medical Knowledge Group, LLC"

Quick Search

Relevant Topics

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...